Genmab | GEN - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Almirall EUR 19.58M 7M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 1.82B 486M 2026-03
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Demant DKK 427M 690M 2025-12
Exelixis USD 210.47M 34.06M 2026-03
Fresenius Medical Care EUR 118M 209M 2026-03
Genmab DKK 31M 370M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GN Store Nord DKK -955M 1.3B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Insmed USD -163.56M 164.92M 2026-03
Lakefront Biotherapeutics EUR 14.49M 767.65M 2026-03
Lonza CHF 426M 119M 2025-06
Merck EUR 659M 340M 2026-03
Novartis USD 3.16B 747M 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 1.61B 2.42B 2026-03
UCB EUR 1.08B 608M 2025-12